A Study of the Effects of Advantage 24 on the Rectum

NCT00000929 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Nonoxynol-9

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)